Loading…

Ocular involvement in metastatic and systemic malignancies is not rare

Background Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body. Aim The aim of this study is to evaluate the com...

Full description

Saved in:
Bibliographic Details
Published in:Cancer reports 2021-08, Vol.4 (4), p.e1347-n/a
Main Authors: Sthapit, Purnima Rajkarnikar, Saiju, Rohit
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3
cites cdi_FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3
container_end_page n/a
container_issue 4
container_start_page e1347
container_title Cancer reports
container_volume 4
creator Sthapit, Purnima Rajkarnikar
Saiju, Rohit
description Background Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body. Aim The aim of this study is to evaluate the common eye and orbital structures involved in secondary ocular and metastatic disease, to describe its clinical manifestations and outline the management done. Methods A retrospective study of newly diagnosed cases of ocular metastasis in last 2 years conducted in our recently established department of ocular oncology at a tertiary eye care hospital in Nepal. Demography, age and sex distribution were noted. The patients were segregated into those with secondary or metastatic ocular malignancies. Detail study on the metastatic disease to eye was made in regards to presenting symptoms, signs, primary site of cancer, and the treatment done. Details of the investigations done, like biopsy and imaging were also recorded. Results There were a total of 28 patients, whose age group ranged from 9 years to 69 years with median age of 43 years. Females constituted 46% of total patients. Both the eyes were involved in 9 patients (32%). Eye was secondarily involved by paranasal sinus tumors and Non Hodgkin lymphoma (7 patients each). Ocular metastasis was commonly seen from broncogenic carcinoma in four and breast carcinoma in three patients. Simultaneous metastasis to other parts of the body was also seen in 61% of our patients. Diminution of vision in 49% was the most common presenting feature followed by proptosis in 16% and palpable mass in 14% of patients. Orbit in 43% cases is the commonest ocular structure involved. Histopathologic diagnosis was done in 32% only while rest was based on imaging alone. The most common treatment done was chemotherapy in 57% patients. Conclusion Ocular metastasis can display a wide variety of clinical and imaging features and therefore a high degree of suspicion is required. It is often associated with simultaneous metastasis to other parts of the body as well, hence the importance of earlier diagnosis and metastatic workup.
doi_str_mv 10.1002/cnr2.1347
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3876e74752e04e299315a77881bca65c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3876e74752e04e299315a77881bca65c</doaj_id><sourcerecordid>3090225161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3</originalsourceid><addsrcrecordid>eNp1kV1LHDEUhkNpqWK96B8oA72pF6v5zsxNoSy1FaRC0etwJnNmm2UmscnMlv33Zl0VLXiVr4eH9-Ql5COjp4xSfuZC4qdMSPOGHHJlxKIWsn77bH9AjnNeU0pZrQVvxHtyIIQSihtxSM6v3DxAqnzYxGGDI4ap7KsRJ8gTTN5VELoqb_OEYzmMMPhVgOA85srnKsSpSpDwA3nXw5Dx-GE9Ijfn36-XPxeXVz8ult8uF04ZbRadFMg1065ThqEEx3toRC8Z65qurxlzFLVuSui-5VxxYQz0sm01NKjaBsURudh7uwhre5v8CGlrI3h7fxHTykIqqQe0ojYajTSKI5XIm0YwBcbUNWsdaOWK6-vedTu3I3aujJ5geCF9-RL8H7uKG1uLIjG0CL48CFL8O2Oe7Oizw2GAgHHOlstaSy0ZZQX9_B-6jnMK5ausoA0tszK9o072lEsx54T9UxhG7a5suyvb7sou7Kfn6Z_Ix2oLcLYH_vkBt6-b7PLXb36vvAPd3bJ2</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3090225161</pqid></control><display><type>article</type><title>Ocular involvement in metastatic and systemic malignancies is not rare</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Sthapit, Purnima Rajkarnikar ; Saiju, Rohit</creator><creatorcontrib>Sthapit, Purnima Rajkarnikar ; Saiju, Rohit</creatorcontrib><description>Background Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body. Aim The aim of this study is to evaluate the common eye and orbital structures involved in secondary ocular and metastatic disease, to describe its clinical manifestations and outline the management done. Methods A retrospective study of newly diagnosed cases of ocular metastasis in last 2 years conducted in our recently established department of ocular oncology at a tertiary eye care hospital in Nepal. Demography, age and sex distribution were noted. The patients were segregated into those with secondary or metastatic ocular malignancies. Detail study on the metastatic disease to eye was made in regards to presenting symptoms, signs, primary site of cancer, and the treatment done. Details of the investigations done, like biopsy and imaging were also recorded. Results There were a total of 28 patients, whose age group ranged from 9 years to 69 years with median age of 43 years. Females constituted 46% of total patients. Both the eyes were involved in 9 patients (32%). Eye was secondarily involved by paranasal sinus tumors and Non Hodgkin lymphoma (7 patients each). Ocular metastasis was commonly seen from broncogenic carcinoma in four and breast carcinoma in three patients. Simultaneous metastasis to other parts of the body was also seen in 61% of our patients. Diminution of vision in 49% was the most common presenting feature followed by proptosis in 16% and palpable mass in 14% of patients. Orbit in 43% cases is the commonest ocular structure involved. Histopathologic diagnosis was done in 32% only while rest was based on imaging alone. The most common treatment done was chemotherapy in 57% patients. Conclusion Ocular metastasis can display a wide variety of clinical and imaging features and therefore a high degree of suspicion is required. It is often associated with simultaneous metastasis to other parts of the body as well, hence the importance of earlier diagnosis and metastatic workup.</description><identifier>ISSN: 2573-8348</identifier><identifier>EISSN: 2573-8348</identifier><identifier>DOI: 10.1002/cnr2.1347</identifier><identifier>PMID: 33535273</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Adolescent ; Adult ; Age groups ; Aged ; Biopsy ; Breast cancer ; Carcinoma, Bronchogenic - epidemiology ; Carcinoma, Bronchogenic - secondary ; Chemotherapy ; Child ; choroidal metastasis ; Ewings sarcoma ; eye cancer ; Eye Neoplasms - epidemiology ; Eye Neoplasms - secondary ; Eye Neoplasms - therapy ; Female ; Females ; Humans ; Leukemia ; Lung Neoplasms - pathology ; Lymphoma ; Male ; Males ; Metastasis ; Middle Aged ; Multiple myeloma ; Nepal - epidemiology ; ocular malignancy ; ocular metastasis ; Oncology ; orbital metastasis ; Orbital Neoplasms - epidemiology ; Orbital Neoplasms - secondary ; Orbital Neoplasms - therapy ; Original ; Paranasal Sinus Neoplasms - pathology ; Patients ; Retrospective Studies ; Sinuses ; Surgery ; Tumors ; Visual acuity ; Young Adult</subject><ispartof>Cancer reports, 2021-08, Vol.4 (4), p.e1347-n/a</ispartof><rights>2021 The Authors. published by Wiley Periodicals LLC.</rights><rights>2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3</citedby><cites>FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3</cites><orcidid>0000-0001-5210-7318</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388170/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3090225161?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,25731,27901,27902,36989,36990,44566,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33535273$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sthapit, Purnima Rajkarnikar</creatorcontrib><creatorcontrib>Saiju, Rohit</creatorcontrib><title>Ocular involvement in metastatic and systemic malignancies is not rare</title><title>Cancer reports</title><addtitle>Cancer Rep (Hoboken)</addtitle><description>Background Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body. Aim The aim of this study is to evaluate the common eye and orbital structures involved in secondary ocular and metastatic disease, to describe its clinical manifestations and outline the management done. Methods A retrospective study of newly diagnosed cases of ocular metastasis in last 2 years conducted in our recently established department of ocular oncology at a tertiary eye care hospital in Nepal. Demography, age and sex distribution were noted. The patients were segregated into those with secondary or metastatic ocular malignancies. Detail study on the metastatic disease to eye was made in regards to presenting symptoms, signs, primary site of cancer, and the treatment done. Details of the investigations done, like biopsy and imaging were also recorded. Results There were a total of 28 patients, whose age group ranged from 9 years to 69 years with median age of 43 years. Females constituted 46% of total patients. Both the eyes were involved in 9 patients (32%). Eye was secondarily involved by paranasal sinus tumors and Non Hodgkin lymphoma (7 patients each). Ocular metastasis was commonly seen from broncogenic carcinoma in four and breast carcinoma in three patients. Simultaneous metastasis to other parts of the body was also seen in 61% of our patients. Diminution of vision in 49% was the most common presenting feature followed by proptosis in 16% and palpable mass in 14% of patients. Orbit in 43% cases is the commonest ocular structure involved. Histopathologic diagnosis was done in 32% only while rest was based on imaging alone. The most common treatment done was chemotherapy in 57% patients. Conclusion Ocular metastasis can display a wide variety of clinical and imaging features and therefore a high degree of suspicion is required. It is often associated with simultaneous metastasis to other parts of the body as well, hence the importance of earlier diagnosis and metastatic workup.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age groups</subject><subject>Aged</subject><subject>Biopsy</subject><subject>Breast cancer</subject><subject>Carcinoma, Bronchogenic - epidemiology</subject><subject>Carcinoma, Bronchogenic - secondary</subject><subject>Chemotherapy</subject><subject>Child</subject><subject>choroidal metastasis</subject><subject>Ewings sarcoma</subject><subject>eye cancer</subject><subject>Eye Neoplasms - epidemiology</subject><subject>Eye Neoplasms - secondary</subject><subject>Eye Neoplasms - therapy</subject><subject>Female</subject><subject>Females</subject><subject>Humans</subject><subject>Leukemia</subject><subject>Lung Neoplasms - pathology</subject><subject>Lymphoma</subject><subject>Male</subject><subject>Males</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Multiple myeloma</subject><subject>Nepal - epidemiology</subject><subject>ocular malignancy</subject><subject>ocular metastasis</subject><subject>Oncology</subject><subject>orbital metastasis</subject><subject>Orbital Neoplasms - epidemiology</subject><subject>Orbital Neoplasms - secondary</subject><subject>Orbital Neoplasms - therapy</subject><subject>Original</subject><subject>Paranasal Sinus Neoplasms - pathology</subject><subject>Patients</subject><subject>Retrospective Studies</subject><subject>Sinuses</subject><subject>Surgery</subject><subject>Tumors</subject><subject>Visual acuity</subject><subject>Young Adult</subject><issn>2573-8348</issn><issn>2573-8348</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kV1LHDEUhkNpqWK96B8oA72pF6v5zsxNoSy1FaRC0etwJnNmm2UmscnMlv33Zl0VLXiVr4eH9-Ql5COjp4xSfuZC4qdMSPOGHHJlxKIWsn77bH9AjnNeU0pZrQVvxHtyIIQSihtxSM6v3DxAqnzYxGGDI4ap7KsRJ8gTTN5VELoqb_OEYzmMMPhVgOA85srnKsSpSpDwA3nXw5Dx-GE9Ijfn36-XPxeXVz8ult8uF04ZbRadFMg1065ThqEEx3toRC8Z65qurxlzFLVuSui-5VxxYQz0sm01NKjaBsURudh7uwhre5v8CGlrI3h7fxHTykIqqQe0ojYajTSKI5XIm0YwBcbUNWsdaOWK6-vedTu3I3aujJ5geCF9-RL8H7uKG1uLIjG0CL48CFL8O2Oe7Oizw2GAgHHOlstaSy0ZZQX9_B-6jnMK5ausoA0tszK9o072lEsx54T9UxhG7a5suyvb7sou7Kfn6Z_Ix2oLcLYH_vkBt6-b7PLXb36vvAPd3bJ2</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Sthapit, Purnima Rajkarnikar</creator><creator>Saiju, Rohit</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5210-7318</orcidid></search><sort><creationdate>202108</creationdate><title>Ocular involvement in metastatic and systemic malignancies is not rare</title><author>Sthapit, Purnima Rajkarnikar ; Saiju, Rohit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age groups</topic><topic>Aged</topic><topic>Biopsy</topic><topic>Breast cancer</topic><topic>Carcinoma, Bronchogenic - epidemiology</topic><topic>Carcinoma, Bronchogenic - secondary</topic><topic>Chemotherapy</topic><topic>Child</topic><topic>choroidal metastasis</topic><topic>Ewings sarcoma</topic><topic>eye cancer</topic><topic>Eye Neoplasms - epidemiology</topic><topic>Eye Neoplasms - secondary</topic><topic>Eye Neoplasms - therapy</topic><topic>Female</topic><topic>Females</topic><topic>Humans</topic><topic>Leukemia</topic><topic>Lung Neoplasms - pathology</topic><topic>Lymphoma</topic><topic>Male</topic><topic>Males</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Multiple myeloma</topic><topic>Nepal - epidemiology</topic><topic>ocular malignancy</topic><topic>ocular metastasis</topic><topic>Oncology</topic><topic>orbital metastasis</topic><topic>Orbital Neoplasms - epidemiology</topic><topic>Orbital Neoplasms - secondary</topic><topic>Orbital Neoplasms - therapy</topic><topic>Original</topic><topic>Paranasal Sinus Neoplasms - pathology</topic><topic>Patients</topic><topic>Retrospective Studies</topic><topic>Sinuses</topic><topic>Surgery</topic><topic>Tumors</topic><topic>Visual acuity</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sthapit, Purnima Rajkarnikar</creatorcontrib><creatorcontrib>Saiju, Rohit</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Cancer reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sthapit, Purnima Rajkarnikar</au><au>Saiju, Rohit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular involvement in metastatic and systemic malignancies is not rare</atitle><jtitle>Cancer reports</jtitle><addtitle>Cancer Rep (Hoboken)</addtitle><date>2021-08</date><risdate>2021</risdate><volume>4</volume><issue>4</issue><spage>e1347</spage><epage>n/a</epage><pages>e1347-n/a</pages><issn>2573-8348</issn><eissn>2573-8348</eissn><abstract>Background Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body. Aim The aim of this study is to evaluate the common eye and orbital structures involved in secondary ocular and metastatic disease, to describe its clinical manifestations and outline the management done. Methods A retrospective study of newly diagnosed cases of ocular metastasis in last 2 years conducted in our recently established department of ocular oncology at a tertiary eye care hospital in Nepal. Demography, age and sex distribution were noted. The patients were segregated into those with secondary or metastatic ocular malignancies. Detail study on the metastatic disease to eye was made in regards to presenting symptoms, signs, primary site of cancer, and the treatment done. Details of the investigations done, like biopsy and imaging were also recorded. Results There were a total of 28 patients, whose age group ranged from 9 years to 69 years with median age of 43 years. Females constituted 46% of total patients. Both the eyes were involved in 9 patients (32%). Eye was secondarily involved by paranasal sinus tumors and Non Hodgkin lymphoma (7 patients each). Ocular metastasis was commonly seen from broncogenic carcinoma in four and breast carcinoma in three patients. Simultaneous metastasis to other parts of the body was also seen in 61% of our patients. Diminution of vision in 49% was the most common presenting feature followed by proptosis in 16% and palpable mass in 14% of patients. Orbit in 43% cases is the commonest ocular structure involved. Histopathologic diagnosis was done in 32% only while rest was based on imaging alone. The most common treatment done was chemotherapy in 57% patients. Conclusion Ocular metastasis can display a wide variety of clinical and imaging features and therefore a high degree of suspicion is required. It is often associated with simultaneous metastasis to other parts of the body as well, hence the importance of earlier diagnosis and metastatic workup.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33535273</pmid><doi>10.1002/cnr2.1347</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-5210-7318</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2573-8348
ispartof Cancer reports, 2021-08, Vol.4 (4), p.e1347-n/a
issn 2573-8348
2573-8348
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_3876e74752e04e299315a77881bca65c
source Open Access: Wiley-Blackwell Open Access Journals; Wiley-Blackwell Read & Publish Collection; Publicly Available Content (ProQuest); PubMed Central
subjects Adolescent
Adult
Age groups
Aged
Biopsy
Breast cancer
Carcinoma, Bronchogenic - epidemiology
Carcinoma, Bronchogenic - secondary
Chemotherapy
Child
choroidal metastasis
Ewings sarcoma
eye cancer
Eye Neoplasms - epidemiology
Eye Neoplasms - secondary
Eye Neoplasms - therapy
Female
Females
Humans
Leukemia
Lung Neoplasms - pathology
Lymphoma
Male
Males
Metastasis
Middle Aged
Multiple myeloma
Nepal - epidemiology
ocular malignancy
ocular metastasis
Oncology
orbital metastasis
Orbital Neoplasms - epidemiology
Orbital Neoplasms - secondary
Orbital Neoplasms - therapy
Original
Paranasal Sinus Neoplasms - pathology
Patients
Retrospective Studies
Sinuses
Surgery
Tumors
Visual acuity
Young Adult
title Ocular involvement in metastatic and systemic malignancies is not rare
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T08%3A26%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20involvement%20in%20metastatic%20and%20systemic%20malignancies%20is%20not%20rare&rft.jtitle=Cancer%20reports&rft.au=Sthapit,%20Purnima%20Rajkarnikar&rft.date=2021-08&rft.volume=4&rft.issue=4&rft.spage=e1347&rft.epage=n/a&rft.pages=e1347-n/a&rft.issn=2573-8348&rft.eissn=2573-8348&rft_id=info:doi/10.1002/cnr2.1347&rft_dat=%3Cproquest_doaj_%3E3090225161%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3090225161&rft_id=info:pmid/33535273&rfr_iscdi=true